drugset / Trial / NCT01410162
Advagraf/Prograf Conversion Trial
RandomizedCrossoverOpen-labelTreatment
Summary
Renal and kidney pancreas transplant patients will be randomized to once daily Advagraf or twice daily Prograf to assess changes in tacrolimus and mycophenolate mofetil exposure, renal allograft function, other relevant biochemical parameters and treatment related adverse effects.
Timeline
- Start
- 2010-12
- Primary completion
- 2014-02
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tacrolimus | Small molecule | — | — |
Indications
No indication recorded.